Considering these findings, study aimed to further explore whether TCF21 genetic polymorphisms affected susceptibility to stable angina and ST elevation myocardial infarction (STEMI) and their relationships with clinical and biochemical characteristics. The gene discussed is TCF21; the disease is ST Elevation Myocardial Infarction.